Robert Duggan is an American entrepreneur who has a net worth of $1.97 billion. After making investments in several tech companies, a pioneering robotic surgery company and a cookie bakery, Robert Duggan became a billionaire as shareholder and CEO of pharmaceutical company called Pharmacyclics. The company pioneered a cancer drug Ibrutinib that treats chronic lymphocytic leukemia and is dubbed the most promising leukemia drug in a decade.
Owning almost one-fifth of the company’s shares, Robert Duggan saw an incredible surge in his net worth along with an almost 1,000% boost of the company’s stock in the past two years. A portion of his abundant fortune will be donated to the Church of Scientology, of which he is an active member.
| Net Worth: | $1.97 Billion |
| Gender: | Male |